Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal. (2019)
Attributed to:
VAccine deveLopment for complex Intracellular neglecteD pAThogEns (VALIDATE)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/infdis/jiy639
PubMed Identifier: 30407513
Publication URI: http://europepmc.org/abstract/MED/30407513
Type: Journal Article/Review
Volume: 219
Parent Publication: The Journal of infectious diseases
Issue: 8
ISSN: 0022-1899